醒脑静注射液治疗脑梗塞的临床疗效观察

Clinical efficacy of the Xingnaojing injection on cerebral infarction

目的:观察在临床治疗脑梗塞患者时采用醒脑静注射液的临床疗效。方法:选取我院收治的68例脑梗塞患者,并分为对照组34例和观察组34例,分别采用复方丹参注射液、醒脑静注射液进行治疗,比较两组治疗前后的神经功能缺损程度以及临床疗效。结果:治疗后,两组患者的Barthel指数评分、神经功能缺损评分均较治疗前显著改善,观察组的改善程度明显较对照组优,差异显著(P<0.05);观察组与对照组的临床治疗总有效率分别为91.2%、73.5%,观察组的治疗总有效率明显高于对照组(P<0.05)。结论:在脑梗塞患者的临床治疗中采用醒脑静注射液,能够使患者的神经功能缺损得到显著改善,值得临床推广使用。

Objective： To observe clinical efficacy of the Xingnaojing injection on cerebral infarction. Methods： 68 patients in our hospital were randomly divided into two groups, 34 cases for each. The control group was given the Fufang Danshen injection; and the observation group was given the Xingnaojing injection. Neurological impairment and clinical efficacy in two groups were compared. Results： After treatment, Bartbel score and neurological deficit scores in two groups were improved, and those in the observation group were better （P〈0.05）. The total efficiency was 91.2% in the observation group, better than 73.5% in the control group （P〈0.05）. Conclusion： The Xingnaojing injection on cerebral infarction shows a good effect, improves neurological deficit scores, and is worthy of promotion.